Advancing new potential treatments for certain GI diseases affecting millions of patients in need
Status of selected key development programs as of February 25, 2020. Represents ongoing phase of development; does not correspond to completion of a particular phase.
Copyright © 2020, Ironwood Pharmaceuticals, Inc. All Rights Reserved
LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.